References
- ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123:202–216.
- Miller VM, Kling JM, Files JA, et al. What’s in a name: are menopausal “hot flashes” a symptom of menopause or a manifestation of neurovascular dysregulation? Menopause. 2018;25:700–703.
- Borud EK, Alraek T, White A, et al. The acupuncture on hot flushes among menopausal women (ACUFLASH) study, a randomized controlled trial. Menopause. 2009;16:484–493.
- Llaneza P. Clinical symptoms and quality of life: hot flashes and mood. In Antonio Cano, editor. Menopause. Cham: Springer; 2017. p. 69–78.
- Sturdee D, Hunter M, Maki P, et al. The menopausal hot flush: a review. Climacteric. 2017;20:296–305.
- Smith RL, Gallicchio LM, Flaws JA. Understanding the complex relationships underlying hot flashes: a Bayesian Network Approach. Menopause. 2017;25:1–90.
- MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2001;1:CD002978.
- Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA. 2004;291:1610–1620.
- Rossouw JE. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333.
- Woods NF, Utian W. Quality of life, menopause, and hormone therapy: an update and recommendations for future research. Menopause. 2018;25:713–720.
- Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409.
- Bakken K, Fournier A, Lund E, et al. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128:144–156.
- Barton DL, Loprinzi CL, Novotny P, et al. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol. 2003;1:47–51.
- Stubbs C, Mattingly L, Crawford SA, et al. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women. J Okla State Med Assoc. 2017;110:272.
- Ahmad A, Husain A, Mujeeb M, et al. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac JTrop Biomed 2013;3:337–352.
- Koshak A, Koshak E, Heinrich M. Medicinal benefits of Nigella sativa in bronchial asthma: a literature review. Saudi Pharm J. 2017;25:1130–1136.
- Peters S. Nigella sativa: a core consideration for atopy and histamine mediated disorders. J Aust Tradit Med Soc. 2018;24:56.
- Rotem C, Kaplan B. Phyto-Female complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol. 2007;23:117–122.
- Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. 2001;322:134–137.
- Rafieian-Kopaei M, Movahedi M. Systematic review of premenstrual, postmenstrual and infertility disorders of Vitex agnus castus. Electron Physician. 2017;9:3685.
- Chen S-N, Friesen JB, Webster D, et al. Phytoconstituents from Vitex agnus-castus fruits. Fitoterapia. 2011;82:528–533.
- Zamani M, Neghab N, Torabian S. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med Iran. 2012;50:101–116.
- Wuttke W, Jarry H, Seidlova-Wuttke D, et al. The use of chasteberry extract (Vitex agnus castus). In Gynecology. Gynakologische Endokrinologie. 2008;6:82–86.
- Webster DE, He Y, Chen S-N, et al. Opioidergic mechanisms underlying the actions of Vitex agnus-castus L. Biochem Pharmacol. 2011;81:170–177.
- Niroumand MC, Heydarpour F, Farzaei MH. Pharmacological and therapeutic effects of Vitex agnus-castus L.: a review. Pharmacognosy Rev. 2018;12:103.
- Dericks-Tan J, Schwinn P, Hildt C. Dose-dependent stimulation of melatonin secretion after administration of Agnus castus. Exp Clin Endocrinol Diab. 2003;111:44–46.
- van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern Complement Med. 2009;15:853–862.
- Latiff LA, Parhizkar S, Dollah MA, Hassan STS. Alternative supplement for enhancement of reproductive health and metabolic profile among perimenopausal women: a novel role of Nigella sativa. Iran J Basic Med Sci. 2014;17:980.
- Ibrahim RM, Hamdan NS, Ismail M, et al. Protective effects of Nigella sativa on metabolic syndrome in menopausal women. Adv Pharm Bull. 2014;4:29.
- Parhizkar S, Latiff LA, Rahman SA, Dollah MA. Preventive effect of Nigella sativa on metabolic syndrome in menopause induced rats. J Med Plants Res. 2011;5:1478–1484.
- Valizadeh N, Zakeri H, Shafiee A, et al. Impact of Black seed (Nigella sativa) extract on bone turnover markers in postmenopausal women with osteoporosis. DARU J Pharm Sci. 2015;1:20–25.
- Seif AA. Nigella Sativa reverses osteoporosis in ovariectomized rats. BMC Complement Altern Med. 2014;14:22.
- Parhizkarsup S, Latiffsup LA, Rahmansup SA, et al. Assessing estrogenic activity of Nigella sativa in ovariectomized rats using vaginal cornification assay. Afr J Pharm Pharmacol. 2011;5:137–142.
- Parhizkar S, Latiff LA, Rahman SA, et al. In vivo estrogenic activity of Nigella sativa different extracts using vaginal cornification assay. J Med Plants Res. 2011;5:6939–6945.